Portfolio Penny

News and resources from the financial markets, real estate and alternative investments. But never advice on anything, financial or personal. That's on you!

[Portfolio Penny @PortfolioPenny]

$GOVX working on addressing the shortage of available #MPOX vaccine. Update from CEO on the disease and the growing need here. https://t.co/Og9U3OMU5m

[Portfolio Penny @PortfolioPenny]

GeoVax Labs, Inc. (GOVX-NASDAQ) is progressing several clinical trials, crucial for patients with compromised immune systems and those suffering from head and neck cancers. Comprehensive 17-page Research Update now available. https://t.co/oPiXJCNN9s.

[Portfolio Penny @PortfolioPenny]

Fat cells have epigenetics-based memory: Researchers discover mechanism behind weight loss yo-yo effect https://t.co/fbbUAxY1Eh

[Portfolio Penny @PortfolioPenny]

#mpox https://t.co/Gfc3Wr0rFK

[Portfolio Penny @PortfolioPenny]

Registration Is Now Open for Tribe Public’s Webinar Event
"Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO. https://t.co/P0xv2w71qk #mpox #vaccine $GOVX

[Portfolio Penny @PortfolioPenny]

Have a question about the state of an #Mpoxvaccine ? $GOVX GeoVax Labs to Present at the Emerging Growth Conference on August 21, 2024
[email protected]

[Portfolio Penny @PortfolioPenny]

GeoVax Shares Are Making Big Moves: What's Going On? https://t.co/Teb1fLf4of

[Portfolio Penny @PortfolioPenny]

Trends in the approval of cancer therapies by the FDA in the twenty-first century - Nature Reviews Drug Discovery https://t.co/HJsONVjc6k

[Portfolio Penny @PortfolioPenny]

GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, will present at the 36th Annual Roth Conference in Dana Point, CA, on March 17-19, 2024. https://t.co/4MRJK9MBxC

[Portfolio Penny @PortfolioPenny]

https://t.co/jbG2Lok5pF

[Portfolio Penny @PortfolioPenny]

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine #vaccines #COVID19 #immunocompromised #MVA $GOVX https://t.co/Wv0gHMhUGj

[Portfolio Penny @PortfolioPenny]

$3.1 Billion remaining to be awarded to companies developing Covid vaccines.

https://t.co/cCr3RUjFUL

[Portfolio Penny @PortfolioPenny]

The conference for innovators. See presentation time and company info. #biotech #demycolton #healthcare #BioFuture2023
https://t.co/SYxQIzqX7o

[Portfolio Penny @PortfolioPenny]

It's time for innovators. See presentation time and company info. #biotech #demycolton #healthcare #BioFuture2023
https://t.co/lB5a6aNIV1

[Portfolio Penny @PortfolioPenny]

Innovators in #biotech come together #demycolton #healthcare #BioFuture2023 See the presentation live.
https://t.co/0v1QSYU4JO

[Portfolio Penny @PortfolioPenny]

Retinitis Pigmentosa (RP) is the leading cause of visual disability and blindness in patients under 60. #RetinitisPigmentosa #blindness #vision #visionrestore $KPRX

https://t.co/HQwoAUnqBx

[Portfolio Penny @PortfolioPenny]

Innovators & Investors Come Together to Shape the Future of Healthcare. #biotech, #demy-colton, #innovators, #disruptors Learn more and register here. https://t.co/rm5vkU8rI8

[Portfolio Penny @PortfolioPenny]

C.D.C. Advisers to Decide Who Should Receive New Covid Vaccines - The New York Times #geovax https://t.co/2Qr92Jk2Z6

[Portfolio Penny @PortfolioPenny]

CDC issues warning over flesh-eating bacteria killing Americans - The Columbus Dispatch #immunocompromised #feedly https://t.co/WkEgZKqut3

[Portfolio Penny @PortfolioPenny]

GeoVax Labs vaccinates first patients in trial of GEO-CM04S1 https://t.co/DUmw83hL76